Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients
In adults, the conditions associated with clinical insulin resistance are gross obesity, severe infection, Cushing's syndrome, acromegaly, hemochromatosis, lipodystrophic diabetes, genetic insulin receptor abnormalities, insulin receptor antibodies, Werner's syndrome (adult form of progeri...
Gespeichert in:
| Veröffentlicht in: | Diabetes care 2006-11, Vol.29 (11), p.2504-2505 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2505 |
|---|---|
| container_issue | 11 |
| container_start_page | 2504 |
| container_title | Diabetes care |
| container_volume | 29 |
| creator | BALLANI, Piya TARN, Michael T NAVAR, Maria D DAVIDSON, Mayer B |
| description | In adults, the conditions associated with clinical insulin resistance are gross obesity, severe infection, Cushing's syndrome, acromegaly, hemochromatosis, lipodystrophic diabetes, genetic insulin receptor abnormalities, insulin receptor antibodies, Werner's syndrome (adult form of progeria), insulin degradation at the injection site, and high tilers of IgG insulin binding antibodies (immune mediated). |
| doi_str_mv | 10.2337/dc06-1478 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68996936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A154561196</galeid><sourcerecordid>A154561196</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-97651b660f103371c07be586d58652b06f44598607a1c2286b7dd8112b506f003</originalsourceid><addsrcrecordid>eNptkd-LFSEUgCWK9rb10D8QEhQEuamjjj4ul37BQi_tszjOmZub15nUoe5_n5d7YyEWkQPnfOdw9EPoJaNXvOv6D6OnijDR60dow0wniZRCP0YbyoQh0hh-gZ6VckcpFULrp-iC9VRJZfgGxW0MKXgXMfxZIAdIHvDvUH_gWyIpxRl2a3QZh1TWRraI5wEKvMd7l3_CGA__SiRDCaW6VHE9LIA5HoMboAaPF1fb4FqeoyeTiwVenOMluv308fv2C7n59vnr9vqGeCF5JaZXkg1K0YnR9jzmaT-A1GpsV_KBqkkIabSivWOec62Gfhw1Y3yQrUZpd4nenuYuef61Qql2H4qHGF2CeS1WaWOU6VQDX_8H3s1rTm03y3lHRdf3pkHkBO1cBBvSNNfs_A4SZBfnBFNo6WsmhVSMmePQqwf4dkbYB_9gw7tTg89zKRkmu-TQvvdgGbVHwfYo2B4FN_bVeeN12MN4T56NNuDNGXClaZ2ySz6Ue05z2bzK7i9c5qpk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223043779</pqid></control><display><type>article</type><title>Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>BALLANI, Piya ; TARN, Michael T ; NAVAR, Maria D ; DAVIDSON, Mayer B</creator><creatorcontrib>BALLANI, Piya ; TARN, Michael T ; NAVAR, Maria D ; DAVIDSON, Mayer B</creatorcontrib><description>In adults, the conditions associated with clinical insulin resistance are gross obesity, severe infection, Cushing's syndrome, acromegaly, hemochromatosis, lipodystrophic diabetes, genetic insulin receptor abnormalities, insulin receptor antibodies, Werner's syndrome (adult form of progeria), insulin degradation at the injection site, and high tilers of IgG insulin binding antibodies (immune mediated).</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dc06-1478</identifier><identifier>PMID: 17065692</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Adult ; Algorithms ; Amino acids ; Biological and medical sciences ; Diabetes ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes. Impaired glucose tolerance ; Dosage and administration ; Drug therapy ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Female ; Humans ; Hypoglycemic Agents - administration & dosage ; Insulin ; Insulin - administration & dosage ; Insulin Resistance ; Male ; Medical sciences ; Metabolic diseases ; Middle Aged ; Obesity ; Obesity - complications ; Patients ; Treatment Outcome ; Type 2 diabetes ; Weight Gain - drug effects</subject><ispartof>Diabetes care, 2006-11, Vol.29 (11), p.2504-2505</ispartof><rights>2007 INIST-CNRS</rights><rights>COPYRIGHT 2006 American Diabetes Association</rights><rights>Copyright American Diabetes Association Nov 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-97651b660f103371c07be586d58652b06f44598607a1c2286b7dd8112b506f003</citedby><cites>FETCH-LOGICAL-c452t-97651b660f103371c07be586d58652b06f44598607a1c2286b7dd8112b506f003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18255005$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17065692$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BALLANI, Piya</creatorcontrib><creatorcontrib>TARN, Michael T</creatorcontrib><creatorcontrib>NAVAR, Maria D</creatorcontrib><creatorcontrib>DAVIDSON, Mayer B</creatorcontrib><title>Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>In adults, the conditions associated with clinical insulin resistance are gross obesity, severe infection, Cushing's syndrome, acromegaly, hemochromatosis, lipodystrophic diabetes, genetic insulin receptor abnormalities, insulin receptor antibodies, Werner's syndrome (adult form of progeria), insulin degradation at the injection site, and high tilers of IgG insulin binding antibodies (immune mediated).</description><subject>Adult</subject><subject>Algorithms</subject><subject>Amino acids</subject><subject>Biological and medical sciences</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Female</subject><subject>Humans</subject><subject>Hypoglycemic Agents - administration & dosage</subject><subject>Insulin</subject><subject>Insulin - administration & dosage</subject><subject>Insulin Resistance</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Obesity - complications</subject><subject>Patients</subject><subject>Treatment Outcome</subject><subject>Type 2 diabetes</subject><subject>Weight Gain - drug effects</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkd-LFSEUgCWK9rb10D8QEhQEuamjjj4ul37BQi_tszjOmZub15nUoe5_n5d7YyEWkQPnfOdw9EPoJaNXvOv6D6OnijDR60dow0wniZRCP0YbyoQh0hh-gZ6VckcpFULrp-iC9VRJZfgGxW0MKXgXMfxZIAdIHvDvUH_gWyIpxRl2a3QZh1TWRraI5wEKvMd7l3_CGA__SiRDCaW6VHE9LIA5HoMboAaPF1fb4FqeoyeTiwVenOMluv308fv2C7n59vnr9vqGeCF5JaZXkg1K0YnR9jzmaT-A1GpsV_KBqkkIabSivWOec62Gfhw1Y3yQrUZpd4nenuYuef61Qql2H4qHGF2CeS1WaWOU6VQDX_8H3s1rTm03y3lHRdf3pkHkBO1cBBvSNNfs_A4SZBfnBFNo6WsmhVSMmePQqwf4dkbYB_9gw7tTg89zKRkmu-TQvvdgGbVHwfYo2B4FN_bVeeN12MN4T56NNuDNGXClaZ2ySz6Ue05z2bzK7i9c5qpk</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>BALLANI, Piya</creator><creator>TARN, Michael T</creator><creator>NAVAR, Maria D</creator><creator>DAVIDSON, Mayer B</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20061101</creationdate><title>Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients</title><author>BALLANI, Piya ; TARN, Michael T ; NAVAR, Maria D ; DAVIDSON, Mayer B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-97651b660f103371c07be586d58652b06f44598607a1c2286b7dd8112b506f003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Algorithms</topic><topic>Amino acids</topic><topic>Biological and medical sciences</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Female</topic><topic>Humans</topic><topic>Hypoglycemic Agents - administration & dosage</topic><topic>Insulin</topic><topic>Insulin - administration & dosage</topic><topic>Insulin Resistance</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Obesity - complications</topic><topic>Patients</topic><topic>Treatment Outcome</topic><topic>Type 2 diabetes</topic><topic>Weight Gain - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BALLANI, Piya</creatorcontrib><creatorcontrib>TARN, Michael T</creatorcontrib><creatorcontrib>NAVAR, Maria D</creatorcontrib><creatorcontrib>DAVIDSON, Mayer B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BALLANI, Piya</au><au>TARN, Michael T</au><au>NAVAR, Maria D</au><au>DAVIDSON, Mayer B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2006-11-01</date><risdate>2006</risdate><volume>29</volume><issue>11</issue><spage>2504</spage><epage>2505</epage><pages>2504-2505</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><abstract>In adults, the conditions associated with clinical insulin resistance are gross obesity, severe infection, Cushing's syndrome, acromegaly, hemochromatosis, lipodystrophic diabetes, genetic insulin receptor abnormalities, insulin receptor antibodies, Werner's syndrome (adult form of progeria), insulin degradation at the injection site, and high tilers of IgG insulin binding antibodies (immune mediated).</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>17065692</pmid><doi>10.2337/dc06-1478</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-5992 |
| ispartof | Diabetes care, 2006-11, Vol.29 (11), p.2504-2505 |
| issn | 0149-5992 1935-5548 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68996936 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Adult Algorithms Amino acids Biological and medical sciences Diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes. Impaired glucose tolerance Dosage and administration Drug therapy Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Humans Hypoglycemic Agents - administration & dosage Insulin Insulin - administration & dosage Insulin Resistance Male Medical sciences Metabolic diseases Middle Aged Obesity Obesity - complications Patients Treatment Outcome Type 2 diabetes Weight Gain - drug effects |
| title | Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T04%3A05%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20experience%20with%20U-500%20regular%20insulin%20in%20obese,%20markedly%20insulin-resistant%20type%202%20diabetic%20patients&rft.jtitle=Diabetes%20care&rft.au=BALLANI,%20Piya&rft.date=2006-11-01&rft.volume=29&rft.issue=11&rft.spage=2504&rft.epage=2505&rft.pages=2504-2505&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/dc06-1478&rft_dat=%3Cgale_proqu%3EA154561196%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223043779&rft_id=info:pmid/17065692&rft_galeid=A154561196&rfr_iscdi=true |